Literature DB >> 20834180

Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake.

Mayumi Nagano1, Kuniyoshi Shimizu, Ryuichiro Kondo, Chickako Hayashi, Daigo Sato, Katsuyuki Kitagawa, Koichiro Ohnuki.   

Abstract

Hericium erinaceus, a well known edible mushroom, has numerous biological activities. Especially hericenones and erinacines isolated from its fruiting body stimulate nerve growth factor (NGF) synthesis, which expects H. erinaceus to have some effects on brain functions and autonomic nervous system. Herein, we investigated the clinical effects of H. erinaceus on menopause, depression, sleep quality and indefinite complaints, using the Kupperman Menopausal Index (KMI), the Center for Epidemiologic Studies Depression Scale (CES-D), the Pittsburgh Sleep Quality Index (PSQI), and the Indefinite Complaints Index (ICI). Thirty females were randomly assigned to either the H. erinaceus (HE) group or the placebo group and took HE cookies or placebo cookies for 4 weeks. Each of the CES-D and the ICI score after the HE intake was significantly lower than that before. In two terms of the ICI, "insentive" and "palpitatio", each of the mean score of the HE group was significantly lower than the placebo group. "Concentration", "irritating" and "anxious" tended to be lower than the placebo group. Our results show that HE intake has the possibility to reduce depression and anxiety and these results suggest a different mechanism from NGF-enhancing action of H. erinaceus.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20834180     DOI: 10.2220/biomedres.31.231

Source DB:  PubMed          Journal:  Biomed Res        ISSN: 0388-6107            Impact factor:   1.203


  18 in total

1.  Anti-obesity activity of Yamabushitake (Hericium erinaceus) powder in ovariectomized mice, and its potentially active compounds.

Authors:  Eri Hiraki; Shoko Furuta; Rika Kuwahara; Naomichi Takemoto; Toshiro Nagata; Taiki Akasaka; Bungo Shirouchi; Masao Sato; Koichiro Ohnuki; Kuniyoshi Shimizu
Journal:  J Nat Med       Date:  2017-02-08       Impact factor: 2.343

2.  Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls.

Authors:  Joseph M Rootman; Maggie Kiraga; Pamela Kryskow; Kalin Harvey; Paul Stamets; Eesmyal Santos-Brault; Kim P C Kuypers; Zach Walsh
Journal:  Sci Rep       Date:  2022-06-30       Impact factor: 4.996

3.  Redox modulation of cellular stress response and lipoxin A4 expression by Hericium Erinaceus in rat brain: relevance to Alzheimer's disease pathogenesis.

Authors:  A Trovato; R Siracusa; R Di Paola; M Scuto; M L Ontario; Ornella Bua; Paola Di Mauro; M A Toscano; C C T Petralia; L Maiolino; A Serra; S Cuzzocrea; Vittorio Calabrese
Journal:  Immun Ageing       Date:  2016-07-09       Impact factor: 6.400

4.  Dietary Supplementation of Hericium erinaceus Increases Mossy Fiber-CA3 Hippocampal Neurotransmission and Recognition Memory in Wild-Type Mice.

Authors:  Federico Brandalise; Valentina Cesaroni; Andrej Gregori; Margherita Repetti; Chiara Romano; Germano Orrù; Laura Botta; Carolina Girometta; Maria Lidia Guglielminetti; Elena Savino; Paola Rossi
Journal:  Evid Based Complement Alternat Med       Date:  2017-01-01       Impact factor: 2.629

5.  Prevention of Early Alzheimer's Disease by Erinacine A-Enriched Hericium erinaceus Mycelia Pilot Double-Blind Placebo-Controlled Study.

Authors:  I-Chen Li; Han-Hsin Chang; Chuan-Han Lin; Wan-Ping Chen; Tsung-Han Lu; Li-Ya Lee; Yu-Wen Chen; Yen-Po Chen; Chin-Chu Chen; David Pei-Cheng Lin
Journal:  Front Aging Neurosci       Date:  2020-06-03       Impact factor: 5.750

6.  Neuroprotective Metabolites of Hericium erinaceus Promote Neuro-Healthy Aging.

Authors:  Elisa Roda; Erica Cecilia Priori; Daniela Ratto; Fabrizio De Luca; Carmine Di Iorio; Paola Angelone; Carlo Alessandro Locatelli; Anthea Desiderio; Lorenzo Goppa; Elena Savino; Maria Grazia Bottone; Paola Rossi
Journal:  Int J Mol Sci       Date:  2021-06-15       Impact factor: 5.923

7.  Protective effects of Hericium erinaceus mycelium and its isolated erinacine A against ischemia-injury-induced neuronal cell death via the inhibition of iNOS/p38 MAPK and nitrotyrosine.

Authors:  Kam-Fai Lee; Jiann-Hwa Chen; Chih-Chuan Teng; Chien-Heng Shen; Meng-Chiao Hsieh; Chien-Chang Lu; Ko-Chao Lee; Li-Ya Lee; Wan-Ping Chen; Chin-Chu Chen; Wen-Shih Huang; Hsing-Chun Kuo
Journal:  Int J Mol Sci       Date:  2014-08-27       Impact factor: 5.923

8.  Hericium erinaceus potentially rescues behavioural motor deficits through ERK-CREB-PSD95 neuroprotective mechanisms in rat model of 3-acetylpyridine-induced cerebellar ataxia.

Authors:  Pit Shan Chong; Sharafuddin Khairuddin; Anna Chung Kwan Tse; Lih Fhung Hiew; Chun Lok Lau; George Lim Tipoe; Man-Lung Fung; Kah Hui Wong; Lee Wei Lim
Journal:  Sci Rep       Date:  2020-09-10       Impact factor: 4.379

9.  Hericium Erinaceus Prevents DEHP-Induced Mitochondrial Dysfunction and Apoptosis in PC12 Cells.

Authors:  Ines Amara; Maria Scuto; Agata Zappalà; Maria Laura Ontario; Antonio Petralia; Salwa Abid-Essefi; Luigi Maiolino; Anna Signorile; Angela Trovato Salinaro; Vittorio Calabrese
Journal:  Int J Mol Sci       Date:  2020-03-20       Impact factor: 5.923

Review 10.  Therapeutic Potential of Hericium erinaceus for Depressive Disorder.

Authors:  Pit Shan Chong; Man-Lung Fung; Kah Hui Wong; Lee Wei Lim
Journal:  Int J Mol Sci       Date:  2019-12-25       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.